Seminars

Thursdays from 11:15am-12:30pm
MTRF 3–204 or Zoom

DateTitle

9/11/2025

SPIRIT 2025 Statement Updated Guideline for Protocols of Randomized Trials

Adeboye Bamgboye, Year 4 PhD Candidate; CODR

9/18/2025

Recent Advances in Epilepsy

Jim White, MD; Adult Epileptologist, Minnesota Epilepsy Group

9/25/2025

Achondroplasia: The Patient Journey from Diagnosis to Treatment

Leo Pratt, PharmD, Sr. Medical Science Liaison;
Emily Coleman, MBA; BioMarin Medical

10/02/2025

 

Cystic Fibrosis (CF) for Scientists and non-CF clinicians

Amita Shenai, PharmD, Sr. Medical Science Liaison; Vertex Pharma

10/09/2025

Olink Proteomics for Biomarker Discovery and Translation in Rare Disease and Drug Development

Roya Bashier, Business Development Manager; Olink Proteomics

Date and Time 

TBD

The Convergence Principle: Our Journey to Pumas AI

Vijay Ivaturi, Principle Scientist; Aditi Murti, MBA, VP, Operations & Business
Intelligence; Pumas AI

10/23/2025

Title TBD

Gregory Plotnikoff, MD, MTS, FACP;
Founder & Medical Director, Minnesota Personalized Medicine

10/30/2025

Economic Analysis of Topical Therapies for Dystrophic Epidermolysis Bullosa

Mohamed Duklef, BPharm; Recent graduate, CODR

4/3/2025

Treatment of Wilson Disease

Brenda Gorsett, PharmD, Associate Director Field Medical Affairs, Orphalan U.S.

11/06/2025

Insights from FDA's 2025 Roadmap to Reduce Animal Use

Chenxu Li, PhD Candidate, ECP

11/13/2025

Title TBD

Sandipan Pati, MD, Professor and Epilepsy Division Director, MINCEP; MnDrive
Scholar; Department of Neurology, UMN Medical School

11/20/2025

AOC Platform Clinical Trials in DM1 and FSHD

Alan Roloff, PhD, Principal Medical Science Liaison; Avidity Biosciences

12/04/2025

Mitochondrial Dysfunction as an Upstream Driver of Rare Disease Phenotypes

Christina Pacak, PhD; Assoc. Professor, Department of Neurology, UMN Medical School